Breast Surgery: Minimally Invasive Diagnosis and Treatment

Clinics in Geriatric Medicine

Volumn 22, Issue 3, 2006, Pages 585-603

  Messinger Rapport, Barbara J ^a   Crowe, Joseph P ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ANESTHESIA; AXILLARY LYMPH NODE; BIOLOGY; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER PAIN; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITION; COMORBIDITY; CONSERVATIVE TREATMENT; COST BENEFIT ANALYSIS; DEFORMITY; DIAGNOSTIC ACCURACY; EXCISION; FAMILY; FUNCTIONAL ASSESSMENT; GERIATRIC ASSESSMENT; GERIATRIC PATIENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH STATUS; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; LIFE EXPECTANCY; LYMPH NODE DISSECTION; MASTECTOMY; MEDICAL DECISION MAKING; MENTAL HEALTH; MENTAL STRESS; MINIMALLY INVASIVE SURGERY; MORBIDITY; MULTIMODALITY CANCER THERAPY; OPERATING ROOM; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT COUNSELING; PHYSICAL CAPACITY; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; RURAL AREA; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR BIOPSY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; QUALITY OF LIFE; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVORS; TAMOXIFEN;

EID: 33745929020     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2006.04.006     Document Type: Review

References (86)

1. US Census Bureau. Census 2000. Available at: http://www.census.gov/main/cen2000.htm. Accessed May 30, 2006.
2. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER). 13 Registries for incidence and mortality, 2000-2002 (2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Bethesda (MD)
3. Older Americans 2004: key indicators of well-being (November 2004), US Government Printing Office, Washington, DC
4. Schonberg M.A., McCarthy E.P., Davis R.B., et al. Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc 52 (2004) 1688-1695
5. Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92 (2000) 550-556
6. Kochanek K., Murphy S., Anderson R., et al. Deaths: final data for 2002. National Vital Statistics Reports 53 5 (2004)
7. Inouye S.K., Peduzzi P.N., Robison J.T., et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 279 (1998) 1187-1193
8. Covinsky K.E., Justice A.C., Rosenthal G.E., et al. Measuring prognosis and case mix in hospitalized elders. The importance of functional status. J Gen Intern Med 12 (1997) 203-208 [comment]
9. Walter L.C., and Covinsky K.E. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285 (2001) 2750-2756 [comments]
10. Gajdos C., Tartter P.I., Bleiweiss I.J., et al. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192 (2001) 698-707
11. Ernster V., Ballard-Barbash R., Barlow W., et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94 (2002) 1546-4
12. Ernster V.L., and Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monographs (1997) 151-156
13. Eusebi V., Feudale E., Foschini M.P., et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11 (1994) 223-235
14. Votron L., D'Hoore W., Swine C., et al. The opinion of general practitioners on the treatment of prostate and breast cancer in elderly people: results of a survey based on clinical models. Clin Oncol (R Coll Radiol) 16 (2004) 474-478
15. Bouchardy C., Rapiti E., Fioretta G., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21 (2003) 3580-3587
16. Crowe Jr. J.P., Patrick R.J., Rybicki L.A., et al. Does ultrasound core breast biopsy predict histologic finding on excisional biopsy?. Am J Surg 186 (2003) 397-399
17. Crowe Jr. J.P., Rim A., Patrick R.J., et al. Does core needle breast biopsy accurately reflect breast pathology?. Surgery 134 (2003) 523-526 [discussion: 526-8]
18. Meyer J.E., Smith D.N., Lester S.C., et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA 281 (1999) 1638-1641
19. Fuhrman G.M., Cederbom G.J., Bolton J.S., et al. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg 227 (1998) 932-939
20. Liberman L. Impact of percutaneous image-guided core biopsy on the clinical management of breast disease. In: Rosen P.P. (Ed). Breast pathology: diagnosis by needle core biopsy (1999), Lippincott Williams & Wilkins, Philadelphia 291-300
21. Lind D.S., Minter R., Steinbach B., et al. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res 78 (1998) 23-26
22. Rubin E., Dempsey P.J., Pile N.S., et al. Needle-localization biopsy of the breast: impact of a selective core needle biopsy program on yield. Radiology 195 (1995) 627-631
23. Crowe Jr. J.P., Rim A., Patrick R., et al. A prospective review of the decline of excisional breast biopsy. Am J Surg 184 (2002) 353-355
24. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
25. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
26. Mallick S., Kakuda J., Qian D., et al. Surgical management of breast cancer in the elderly. Proc Am Soc Clin Oncol 22 (2003) 754a
27. Lazovich D.A., White E., Thomas D.B., et al. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266 (1991) 3433-3438
28. Repetto L., Costantini M., Campora E., et al. A retrospective comparison of detection and treatment of breast cancer in young and elderly patients. Breast Cancer Res Treat 43 (1997) 27-31
29. Wanebo H.J., Cole B., Chung M., et al. Is surgical management compromised in elderly patients with breast cancer?. Ann Surg 225 (1997) 579-586 [discussion: 586-8]
30. Guadagnoli E., Weeks J.C., Shapiro C.L., et al. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 16 (1998) 101-106
31. Djordjevic N., Karanikolic A., and Pesic M. Breast cancer in elderly women. Arch Gerontol Geriatr 39 3 (2004) 291-299
32. Keating N.L., Landrum M.B., Ayanian J.Z., et al. Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer. J Clin Oncol 21 (2003) 4532-4539
33. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
34. Vlastos G., Mirza N.Q., Meric F., et al. Breast conservation therapy as a treatment option for the elderly. The M.D. Anderson experience. Cancer 92 (2001) 1092-1100
35. Solin L.J., Schultz D.J., and Fowble B.L. Ten-year results of the treatment of early-stage breast carcinoma in elderly women using breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys 33 (1995) 45-51
36. Huguenin P., Glanzmann C., and Lutolf U.M. Acute toxicity of curative radiotherapy in elderly patients. Strahlenther Onkol 172 (1996) 658-663
37. Wyckoff J., Greenberg H., Sanderson R., et al. Breast irradiation in the older woman: a toxicity study. J Am Geriatr Soc 42 (1994) 150-152
38. Velanovich V., Gabel M., Walker E.M., et al. Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. J Am Coll Surg 194 (2002) 8-13
39. Hebert-Croteau N., Brisson J., Latreille J., et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85 (1999) 1104-1113
40. Nemoto T., Patel J.K., Rosner D., et al. Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67 (1991) 2079-2082
41. Moffat F.L., and Ketcham A.S. Breast-conserving surgery and selective adjuvant radiation therapy for stage I and II breast cancer. Semin Surg Oncol 8 (1992) 172-176
42. McCready D.R., Chapman J.A., Hanna W.M., et al. Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal patients. Ann Surg Oncol 7 (2000) 562-567
43. Hanna W.M., Kahn H.J., Chapman J.A., et al. Pathologic characteristics of breast cancer that predict for local recurrence after lumpectomy alone. Breast J 5 (1999) 105-111
44. Holli K., Saaristo R., Isola J., et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 84 (2001) 164-169
45. Schnitt S.J., Hayman J., Gelman R., et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77 (1996) 1094-1100
46. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 (1996) 1659-1664
47. Reed M.W., and Morrison J.M. Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast. Br J Surg 76 (1989) 898-900
48. Ortholan C., Hannoun-Levi J.M., Ferrero J.M., et al. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Biol Phys 61 (2005) 154-162
49. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
50. Hannoun-Levi J.M., Courdi A., Marsiglia H., et al. Breast cancer in elderly women: is partial breast irradiation a good alternative?. Breast Cancer Res Treat 81 (2003) 243-251
51. Ribeiro G.G., Magee B., Swindell R., et al. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5 (1993) 278-283
52. Cummings F.J., Gray R., Tormey D.C., et al. Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. J Clin Oncol 11 (1993) 29-35
53. Fisher B., Costantino J., Redmond C., et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320 (1989) 479-484
54. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 4141-4149
55. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
56. Gazet J.C., Ford H.T., Coombes R.C., et al. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20 (1994) 207-214
57. Robertson J.F., Ellis I.O., Elston C.W., et al. Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. Eur J Cancer 28A (1992) 908-910
58. Fentiman I.S., Christiaens M.R., Paridaens R., et al. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 39 (2003) 309-316
59. Bland K.I., Scott-Conner C.E., Menck H., et al. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188 (1999) 586-595 [discussion: 595-6]
60. Polednak A.P. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg 237 (2003) 163-167 [comment]
61. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312 (1985) 674-681
62. Johansen H., Kaae S., and Schiodt T. Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer. A twenty-five-year follow-up of a randomized trial. Acta Oncol (Madr) 29 (1990) 709-715
63. Langlands A.O., Prescott R.J., and Hamilton T. A clinical trial in the management of operable cancer of the breast. Br J Surg 67 (1980) 170-174
64. Atkins H., Hayward J.L., Klugman D.J., et al. Treatment of early breast cancer: a report after ten years of a clinical trial. BMJ 2 (1972) 423-429
65. Hayward J. The Guy's Hospital trials on breast conservation. In: Harris J., Lellman S., and Silen W. (Eds). Conservative management of breast cancer: new surgical and radiotherapeutic techniques (1983), JB Lippincott, Philadelphia 77-90
66. Cabanes P.A., Salmon R.J., Vilcoq J.R., et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet 339 (1992) 1245-1248 [comment]
67. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis. Ann Surg Oncol 6 (1999) 109-116 [comment]
68. Truong P.T., Bernstein V., Wai E., et al. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int J Radiat Oncol Biol Phys 54 (2002) 794-803 [comment]
69. Schwartz GF, Giuliano AE, Veronesi U, Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542-51.
70. Gennari R., Rotmensz N., Perego E., et al. Sentinel node biopsy in elderly breast cancer patients. Surg Oncol 13 (2004) 193-196
71. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
72. Bottomley A., Vanvoorden V., Flechtner H., et al. The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials. On behalf of the EORTC QOL Group and EORTC Data Center. Eur J Cancer 39 (2003) 275-285
73. Bates T., Riley D.L., Houghton J., et al. Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg 78 (1991) 591-594
74. de Haes J.C., Curran D., Aaronson N.K., et al. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer 39 (2003) 945-951
75. Fennessy M., Bates T., MacRae K., et al. Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg 91 (2004) 699-704
76. Moyer A. Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. [erratum: Health Psychol 1997;16:442]. Health Psychol 16 (1997) 284-298
77. Rietman J.S., Dijkstra P.U., Hoekstra H.J., et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 29 (2003) 229-238
78. Rietman J., Dijkstra P., Debreczeni R., et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil 26 (2004) 78-84
79. Rietman J.S., Dijkstra P.U., Geertzen J.H., et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11 (2004) 1018-1024
80. Liljegren G., and Holmberg L. Uppsala-Orebro Breast Cancer Study Group. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer 33 (1997) 193-199
81. Hack T.F., Cohen L., Katz J., et al. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17 (1999) 143-149
82. Katz S.J., Lantz P.M., and Zemencuk J.K. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. J Womens Health Gend Based Med 10 (2001) 659-670
83. Kroenke C.H., Rosner B., Chen W.Y., et al. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 22 (2004) 1849-1856
84. Schover L.R., Yetman R.J., Tuason L.J., et al. Partial mastectomy and breast reconstruction. A comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer 75 (1995) 54-64
85. Hind D., Wyld L., Beverley C.B., et al. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). [systematic review]. Cochrane Database Syst Rev 1 (2006) CD004272
86. Rietman J.S., Dijkstra P.U., Geertzen J.H., et al. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. [erratum: Cancer 2004;100:1991]. Cancer 98 (2003) 690-696 [comment]